https://www.ncbi.nlm.nih.gov/pubmed/31005404 Metabolic liver disease

Mol Genet Metab. 2019 Apr 12. pii: S1096-7192(19)30150-7. doi: 10.1016/j.ymgme.2019.04.002. [Epub ahead of print]

Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases.

Ferreira CR1, Cassiman D2, Blau N3.

Abstract

Inherited metabolic diseases account for about one third of pediatric patients with hepatomegaly, acute liver failure, cirrhosis or cholestasis. Specifically for pediatric acute liver failure, they account for 10-15% of cases, with a mortality of 22-65%. The percentage of acute liver failure caused by an inherited metabolic disease in children <2-3 years of age is even higher, ranging from a third to half of all cases. Metabolic liver disease accounts for 8-13% of all pediatric livertransplantations. Despite this high burden of disease, underdiagnosis remains common. We reviewed and updated the list of known metabolic etiologies associated with various types of metabolic liver involvement, and found 142 relevant inborn errors of metabolism. This represents the second of a series of articles attempting to create and maintain a comprehensive list of clinical and metabolic differential diagnoses according to system involvement.